A Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of Plecanatide in the Treatment of Functional Constipation in Chinese Patients for up to 12 Weeks
Latest Information Update: 19 Jul 2024
At a glance
- Drugs Plecanatide (Primary)
- Indications Constipation
- Focus Therapeutic Use
- Sponsors Shandong Luoxin Pharmaceutical
- 11 Jul 2024 Status changed from active, no longer recruiting to completed.
- 03 Jan 2024 Status changed from recruiting to active, no longer recruiting.
- 13 May 2022 Status changed from not yet recruiting to recruiting.